Cargando…

A docking-based structural analysis of geldanamycin-derived inhibitor binding to human or Leishmania Hsp90

Leishmaniasis is a neglected disease that affects millions of individuals around the world. Regardless of clinical form, treatment is based primarily on the use of pentavalent antimonials. However, such treatments are prolonged and present intense side effects, which lead to patient abandonment in m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palma, Luana Carneiro, Ferreira, Luiz Felipe Gomes Rebello, Petersen, Antonio Luis de Oliveira Almeida, Dias, Beatriz Rocha Simões, Menezes, Juliana Perrone Bezerra de, Moreira, Diogo Rodrigo de Magalhães, Hernandes, Marcelo Zaldini, Veras, Patricia Sampaio Tavares
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791876/ https://www.ncbi.nlm.nih.gov/pubmed/31611575 http://dx.doi.org/10.1038/s41598-019-51239-0

Ejemplares similares

Deciphering the Role Played by Autophagy in Leishmania Infection
por: Veras, Patricia Sampaio Tavares, et al.
Publicado: (2019)

Development of the first geldanamycin-based HSP90 degraders
por: Wurnig, Silas, et al.
Publicado: (2023)

Using Proteomics to Understand How Leishmania Parasites Survive inside the Host and Establish Infection
por: Veras, Patrícia Sampaio Tavares, et al.
Publicado: (2016)

In Search of Biomarkers for Pathogenesis and Control of Leishmaniasis by Global Analyses of Leishmania-Infected Macrophages
por: Veras, Patricia Sampaio Tavares, et al.
Publicado: (2018)

HSP90 Inhibitor Geldanamycin as a Radiation Response Modificator in Human Blood Cells
por: Stankova, Katia, et al.
Publicado: (2015)

Synthesis and biological evaluation of geldanamycin–ferulic acid conjugate as a potent Hsp90 inhibitor
por: Li, Zhenyu, et al.
Publicado: (2019)

An improved route to 19-substituted geldanamycins as novel Hsp90 inhibitors – potential therapeutics in cancer and neurodegeneration
por: Kitson, Russell R. A., et al.
Publicado: (2013)

HSP90 Inhibitors, Geldanamycin and Radicicol, Enhance Fisetin-Induced Cytotoxicity via Induction of Apoptosis in Human Colonic Cancer Cells
por: Wu, Ming-Shun, et al.
Publicado: (2013)

The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments
por: Cortese, Katia, et al.
Publicado: (2013)

Study of interaction energies between residues of the active site of Hsp90 and geldanamycin analogues using quantum mechanics/molecular mechanics methods
por: Vivas-Reyes, Ricardo, et al.
Publicado: (2020)

The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin
por: Kumar, Rajinder, et al.
Publicado: (2003)

Discovery of small molecule inhibitors of Leishmania braziliensis Hsp90 chaperone
por: Batista, Fernanda A. H., et al.
Publicado: (2020)

MAPK1 of Leishmania donovani interacts and phosphorylates HSP70 and HSP90 subunits of foldosome complex
por: Kaur, Pavneet, et al.
Publicado: (2017)

Encapsulation of the HSP-90 Chaperone Inhibitor 17-AAG in Stable Liposome Allow Increasing the Therapeutic Index as Assessed, in vitro, on Leishmania (L) amazonensis Amastigotes-Hosted in Mouse CBA Macrophages
por: Petersen, Antonio Luis de Oliveira Almeida, et al.
Publicado: (2018)

Whey Protein Hydrolysate Enhances HSP90 but Does Not Alter HSP60 and HSP25 in Skeletal Muscle of Rats
por: Moura, Carolina Soares, et al.
Publicado: (2014)

Correction: Whey Protein Hydrolysate Enhances HSP90 but Does Not Alter HSP60 and HSP25 in Skeletal Muscle of Rats
por: Moura, Carolina Soares, et al.
Publicado: (2014)

Advances in Development of New Treatment for Leishmaniasis
por: de Menezes, Juliana Perrone Bezerra, et al.
Publicado: (2015)

Geldanamycin attenuates 3-nitropropionic acid-induced apoptosis and JNK activation through the expression of HSP 70 in striatal cells
por: CHOI, YONG-JOON, et al.
Publicado: (2014)

Catalysis-Enabled Access to Cryptic Geldanamycin Oxides
por: Hilton, Margaret J., et al.
Publicado: (2020)

Molecular docking and pharmacophore studies of heterocyclic compounds as Heat shock protein 90 (Hsp90) Inhibitors
por: Baby, Suby T, et al.
Publicado: (2016)

Combination of In Silico Methods in the Search for Potential CD4(+) and CD8(+) T Cell Epitopes in the Proteome of Leishmania braziliensis
por: e Silva, Rafael de Freitas, et al.
Publicado: (2016)

Geldanamycin-Induced Osteosarcoma Cell Death Is Associated with Hyperacetylation and Loss of Mitochondrial Pool of Heat Shock Protein 60 (Hsp60)
por: Gorska, Magdalena, et al.
Publicado: (2013)

Immunogenicity of Potential CD4(+) and CD8(+) T Cell Epitopes Derived From the Proteome of Leishmania braziliensis
por: e Silva, Rafael de Freitas, et al.
Publicado: (2020)

A New Geldanamycin Analogue from Streptomyces hygroscopicus
por: Zhang, Hao, et al.
Publicado: (2010)

In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195
por: Guedes, Carlos Eduardo Sampaio, et al.
Publicado: (2018)

Degradable Cross-Linked Nanoassemblies as Drug Carriers for Heat Shock Protein 90 Inhibitor 17-N-Allylamino-17-demethoxy-geldanamycin
por: Ponta, Andrei, et al.
Publicado: (2011)

17-ABAG, a novel geldanamycin derivative, inhibits LNCaP-cell proliferation through heat shock protein 90 inhibition
por: LIN, ZHIYUAN, et al.
Publicado: (2015)

Geldanamycin, a ligand of heat shock protein 90, inhibits herpes simplex virus type 2 replication both in vitro and in vivo
por: Li, Yu-Huan, et al.
Publicado: (2012)

Possible Involvement of Hsp90 in the Regulation of Telomere Length and Telomerase Activity During the Leishmania amazonensis Developmental Cycle and Population Proliferation
por: de Oliveira, Beatriz C. D., et al.
Publicado: (2021)

The Hsp90–Sti1 interaction is critical for Leishmania donovani proliferation in both life cycle stages
por: Hombach, Antje, et al.
Publicado: (2013)

Ribosome Profiling Reveals HSP90 Inhibitor Effects on Stage-Specific Protein Synthesis in Leishmania donovani
por: Bifeld, Eugenia, et al.
Publicado: (2018)

Quantitative Proteomics Reveals that Hsp90 Inhibition Dynamically Regulates Global Protein Synthesis in Leishmania mexicana
por: Kalesh, Karunakaran, et al.
Publicado: (2021)

Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
por: Sitko, Krzysztof, et al.
Publicado: (2021)

Cell-to-cell transfer of Leishmania amazonensis amastigotes is mediated by immunomodulatory LAMP-rich parasitophorous extrusions
por: Real, Fernando, et al.
Publicado: (2014)

Corrigendum: Possible Involvement of Hsp90 in the Regulation of Telomere Length and Telomerase Activity During the Leishmania Amazonensis Developmental Cycle and Population Proliferation
por: de Oliveira, Beatriz C. D., et al.
Publicado: (2022)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)

The chaperone system in cancer therapies: Hsp90
por: Basset, Charbel A., et al.
Publicado: (2023)

Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapy
por: Tomasello, G., et al.
Publicado: (2011)

HSP90 and HSP70: Implication in Inflammation Processes and Therapeutic Approaches for Myeloproliferative Neoplasms
por: Sevin, Margaux, et al.
Publicado: (2015)

In Vitro Activity of Geldanamycin Derivatives against Schistosoma japonicum and Brugia malayi
por: Wenkert, David, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_kh5av9c1rtr8dt3fmm6jan7vdo